Search

everythinglearnresearchcommunity

for

Search:↓

Don't combine abiraterone and spironolactone for prostate cancer treatment as it may worsen the disease.

Physical activity, height, and smoking affect prostate cancer risk.

Genetic differences may affect COVID-19 deaths; anti-androgens could be potential treatment.

Researchers developed promising agents for prostate cancer imaging, with the best one showing high potential for clinical use.

Prostate cancer can progress even with low testosterone due to internal hormone production in the tumor.

Androgen deprivation therapy doesn't lower the risk of death from COVID-19 in prostate cancer patients.

Dihydroartemisinin helps reduce prostate enlargement in rats by stopping the growth of prostate cells.

Dutasteride effectively treats benign prostatic hyperplasia, improving symptoms and quality of life.

Treatments for enlarged prostate can cause problems with ejaculation, and less invasive options might preserve sexual function better.

Minoxidil and ranolazine together can reduce the spread of certain breast cancer cells.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

Metformin, a diabetes drug, may also help fight cancer, but more research is needed to understand how.

Some plant-derived compounds may help with hormonal conditions, but more research is needed to confirm their effectiveness.

5-alpha reductase inhibitors can cause sexual, neurologic, endocrine, and cardiovascular side effects, but these are rare and usually stop after ending treatment.

Men over 66 taking medication for prostate enlargement have a higher risk of depression and self-harm, especially in the first 18 months of treatment.

5α-reductase inhibitors increase the risk of sexual dysfunction, especially in men with enlarged prostate.

Lovastatin doesn't improve lower urinary tract symptoms treatment.

α-Blockers and 5-ARIs for BPH can cause sexual dysfunction, including erectile and ejaculatory issues.

Metformin, a diabetes drug, may help prevent and treat various cancers, but more research is needed.

CXXC5 is a protein that controls cell growth and healing processes, and changes in its activity can lead to diseases like cancer and hair loss.

We need better ways to test and understand SARMs to make safer and more effective treatments.

5α-reductase inhibitors like finasteride and dutasteride can help treat skin disorders stimulated by androgens, such as hair loss and acne.

Anti-androgen therapy may boost immunity but increases injection site pain in vaccinated patients.

Scalp cooling is the only FDA-approved method to prevent hair loss from chemotherapy, but other treatments like minoxidil and PRP are being tested.

Bicalutamide may help treat female pattern hair loss.

Shift work disrupts the body's natural clock, leading to health problems.

Lack of sleep in mice leads to prostatitis by reducing certain hormones and activating an inflammatory pathway, which can be temporarily fixed with normal sleep.

Saw palmetto may improve urinary symptoms with fewer sexual side effects compared to some medications.

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

Blocking the androgen receptor in skin cells reduces their growth response to male hormones, suggesting a possible treatment for skin conditions linked to androgens.